Subscribe To
Roche (rhhby) polivy combination for dlbcl gets full approval
Roche (RHHBY) gets full approval for Polivy (polatuzumab vedotin-piiq) in combination with Rituxan, cyc...
April 20, 2023, 3:13 pm
Roche (rhhby) polivy combo backed by fda advisory committee
Roche (RHHBY) gets majority votes from the FDA's Advisory Committee for Polivy combination for the trea...
March 10, 2023, 1:47 pm
Dow jones newswires: fda committee backs roche’s lymphoma treatment
The Swiss pharmaceutical company said Friday that the oncologic drugs advisory committee had voted 11 to two in favor of Po...
March 10, 2023, 7:10 am
Fda committee backs roche's lymphoma treatment
A U.S. Food and Drug Administration committee voted in favor of Roche Holding AG's Polivy antibody drug...
March 10, 2023, 2:10 am
Roche's phase 3 data show lymphoma treatment can reduce disease risks
Roche Holding AG presented new data from a Phase 3 study showing that its Polivy antibody-drug can sign...
December 12, 2022, 2:24 am
Chinese equities and the broader market: livy investment research (podcast)
In this episode we’re joined by Lillian Cheung. We’re discussing Chinese equities like Alibaba (BABA) and its effect on the broader market. Cheung...
December 3, 2022, 12:14 pm